 |
|
|
Daniel B. Rosenbluth, M.D.
Professor of Medicine and Pediatrics
EDUCATION/TRAINING
Columbia University School of Engineering and Applied Science B.S. 1985 Bioengineering
Mount Sinai School of Medicine, New York, NY, M.D. 1989 Medicine
POSITIONS
1989-1992 Internship and Residency, Northwestern University Medical School, Department of Internal Medicine, Chicago, IL
1992-1995 Fellowship, Washington University School of Medicine, Division of Pulmonary and Critical Care Medicine, St. Louis, MO
1994-1995 Instructor in Medicine, Washington University School of Medicine, St. Louis, MO
1995-2000 Assistant Professor of Medicine, Washington University School of Medicine, St. Louis, MO
1995- Director, Adult Cystic Fibrosis Program, Washington University School of Medicine, St. Louis, MO
1998- Associate Director, Cystic Fibrosis Center, Washington University School of Medicine, St. Louis, MO
2000-2007 Associate Professor of Medicine, Pulmonary and Critical Care Medicine Division, Washington University School of Medicine, St. Louis, MO
2000-2007 Associate Professor of Pediatrics, Washington University School of Medicine, St. Louis, MO
2007- Professor of Medicine and Pediatrics, Washington University School of Medicine, St. Louis, MO
OTHER EXPERIENCE AND PROFESSIONAL MEMBERSHIPS
1996- Member, Infection Control Committee, Barnes-Jewish Hospital
1998-1999 Chairman Tracheostomy/Ventilator Support Design Team, Barnes-Jewish Hospital/ Washington University School of Medicine
1999-2000 Member, Clinical Quality Improvement Committee, Health Management Partners, L.L.C., BJC Health System/Washington University School of Medicine
Member, American College of Physicians
Fellow, American College of Chest Physicians
Member, American Thoracic Society
PUBLICATIONS
Peer Reviewed Manuscripts
Rosenbluth D, Goodenberger D. Cystic fibrosis in an elderly woman. Chest 1997, 112:1124-1126.
Hanson V, Horowitz M, Rosenbluth D, Spiera H, Puszkin S: Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50 kd neuronal membrane protein. Journal of Experimental Medicine 1992, 176:565-573.
Book Chapters
Rosenbluth DB, Brody SL. Cystic fibrosis. In: Jameson L, ed. Principles of Molecular Medicine. Totowa, NJ: Humana Press, 1998; 329-338.
Rosenbluth DB. Chapters 37, 38, 42-46, In: Fishman AP, ed. Fishman’s Manual of Pulmonary Diseases and Disorders. McGraw-Hill, 2002.
RESEARCH SUPPORT
Schust02AO 3/01/02-2/28/05
Cystic Fibrosis Found.
Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis using Radiolabeled Fluorodeoxyglucose and PET Imaging.
Overall goals: The major goal of this study is to determine the potential utility of using PET imaging
to monitor pulmonary inflammation in patients with cystic fibrosis.
Rosenbluth (PI) 1995-
Genentech
Epidemiologic study of cystic fibrosis: A multicenter, longitudinal follow-up study of patients with cystic fibrosis for monitoring pulmonary function, pulmonary exacerbations, and the safety of long-term treatment with Pulmozyme (dornase alfa).
Overall goals: The major goal of this study is to follow the longitudinal course of cystic fibrosis in a large cohort of patients.
Cystic Fibrosis Foundation
Therapeutics, Inc.
Project: Therapeutics Development Center
Project Period: 11/1/03-10/31/04
Division of Pulmonary and Critical Care Medicine
Department of Medicine
Washington University School of Medicine
|
